Astrazeneca plc

Major-Pharmaceuticals

AZN


1 Francis Crick Avenue
Cambridge , CB2 0AA

Executive/
Director

Price

  • Last Close
  • $ 66.24
    $ +0.36 0.55 %
    Jan 3, 2025
  • 52-Week High/Low
  • $87.54 - $61.03
  • YTD
  • 0%

  • Trading Volume
  • 141,897
  • Market Cap Full
  • $
  • Shares Outstanding

  • Jan 1, 1970
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Q1 17.8% 3.6% 6.5% -5% 1.4% 13.9% 2.4% 0.6% 1.1% -
Q2 9.5% 1.2% -0% 4% 20.1% -0.4% 3.1% 16.8% - -
Q3 0.9% 15% 8.3% 8% 0.3% -17% -5.4% 10.4% - -
Q4 1.3% -3.9% 10.6% -10.6% -3% 23.6% 0.9% 1.4% - -
J F M A M J J A S O N D
2026 - - - - - - - - - - - -
2025 1.1% - - - - - - - - - - -
    2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
    -16%33%14%31%-1%18%16%-1%-3%1%0%

Earnings

2017 2018 2019 2020 2021 2022 2023
Q1 0.99 0.14 0.24 0.3 0.59 0.13 0.58
Q2 0.87 0.14 0.05 0.29 0.21 0.12 0.58
Q3 1.12 0.17 0.23 0.25 -0.55 0.53 0.44
Q4 1.30 0.41 0.12 0.39 -0.22 0.29 -
A 4.3 0.9 0.6 1.2 0 1.07 1.6

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2021 2022 2023 2024
Q1 0.93 0.97 0.97 0.97
Q2 0.44 0.46 0.46 0.49
Q3 - - - -
Q4 - - - -
A 1.37 1.43 1.43 1.46
Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2.6 1.4 1.3 1.5 1.7
Fixed Asset Turnover 4.6 3.6 2.8 2.7 2.6
Total Asset Turnover 0.5 0.4 0.4 0.4 0.4
Leverage
Debt Ratio 1 1.1 0.9 1 1.1
Debt – Equity Ratio 0.6 0.7 1.1 1.1 1.2
Interest Coverage 8 1.1 2.6 1.8 2.8
Equity multiplier 0.3 0.3 0.6 0.6 0.6